Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Jan Hansmann is a pioneering researcher at the intersection of robotics and biomedical engineering, with a core focus on automated biomanufacturing and the development of animal-free testing platforms. His work is driven by the critical need to replace traditional animal models with more ethical, efficient, and reproducible in vitro systems. Dr. Hansmann’s major contributions include the creation of robotic platforms that streamline complex biological processes. His 2023 paper on a robot-based system for automated nanoparticle production (24 citations) demonstrates how human-robot collaboration can enhance process speed, quality, and flexibility for non-experts. He is also the lead behind the ReBiA platform (13 citations), which directly addresses the landmark shift away from mandatory animal testing, as recently mandated by the FDA and advocated by the European Parliament. Furthermore, his 2016 work on a dual-arm robotic system (11 citations) for analyzing reconstructed human epidermis provides a crucial tool for the cosmetic and pharmaceutical industries. By automating the quality control of these skin models, Dr. Hansmann is not only advancing the field of tissue engineering but is also actively building the infrastructure for a more humane and scientifically robust future in drug development and toxicology.